{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "3bc5082f-6b06-4e5e-86d1-5d07c9ebaa36", "code": "N04BA01", "comments": "ATC|NERVOUS SYSTEM|ANTI-PARKINSON DRUGS|DOPAMINERGIC AGENTS|Dopa and dopa derivatives|levodopa", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N04BA01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "f27610cd-78cf-4c1b-84d4-4bed6f71c32e", "code": "N0000175755", "comments": "Cellular or Molecular Interactions [MoA]|Enzyme Interactions [MoA]|Enzyme Inhibitors [MoA]|Catecholamine Synthesis Inhibitors [MoA]|DOPA Decarboxylase Inhibitors [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175755", "code_system": "NDF-RT", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "bf01a059-7272-4b3c-a15c-c3d7c948fcce", "code": "N0000175754", "comments": "Established Pharmacologic Class [EPC]|Aromatic Amino Acid Decarboxylation Inhibitor [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175754", "code_system": "NDF-RT", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "5b2cedb8-b8d4-43bf-be00-549f2da08bdd", "code": "QN04BA01", "comments": "VATC|ANTI-PARKINSON DRUGS|DOPAMINERGIC AGENTS|Dopa and dopa derivatives|levodopa", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN04BA01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "46517b62-dc2f-4ca5-9c33-db31be5c0370", "code": "QN04BA02", "comments": "VATC|ANTI-PARKINSON DRUGS|DOPAMINERGIC AGENTS|Dopa and dopa derivatives|levodopa and decarboxylase inhibitor", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN04BA02&showdescription=yes", "code_system": "WHO-VATC", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "02bd6ab0-d4bf-4b2a-a0d0-7d7c652a69ba", "code": "QN04BA03", "comments": "VATC|ANTI-PARKINSON DRUGS|DOPAMINERGIC AGENTS|Dopa and dopa derivatives|levodopa, decarboxylase inhibitor and COMT inhibitor", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN04BA03&showdescription=yes", "code_system": "WHO-VATC", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "c6d9c891-062d-48a7-a940-629014652166", "code": "59-92-7", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=59-92-7", "code_system": "CAS", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234", "8066292f-e761-4e8a-a2f6-7ae54e16342f" ] }, { "uuid": "2f61cf53-2765-4f43-9f19-391a7268cc29", "code": "D007980", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68007980", "code_system": "MESH", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "a2571578-56b6-4cea-b2d8-e242f5e758ae", "code": "NBK548734", "comments": "LiverTox|CNS|Parkinsons agent|Dopamine precursor", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548734/", "code_system": "LIVERTOX", "references": [ "393c8e4c-9f5a-a3c6-159e-8aa344cb117f" ] }, { "uuid": "0b2c0c6a-4c3a-4f63-b1e7-ba04563f753b", "code": "L-DOPA", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/L-DOPA", "code_system": "WIKIPEDIA", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "139435bb-8217-4aa3-8112-3ccb31923a90", "code": "09 (LEV/CAR)", "comments": "WHO ESSENTIAL MEDICINES LIST|Antiparkinsonism medicines", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/199/?section=82#type499", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "d94be132-de37-4af6-a436-ce0d37d9631d", "code": "N04BA02", "comments": "ATC|NERVOUS SYSTEM|ANTI-PARKINSON DRUGS|DOPAMINERGIC AGENTS|Dopa and dopa derivatives|levodopa and decarboxylase inhibitor", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N04BA02&showdescription=yes", "code_system": "WHO-ATC", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "5a23e91d-01f7-4d9b-a46d-aadb22ce89df", "code": "N04BA03", "comments": "ATC|NERVOUS SYSTEM|ANTI-PARKINSON DRUGS|DOPAMINERGIC AGENTS|Dopa and dopa derivatives|levodopa, decarboxylase inhibitor and COMT inhibitor", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N04BA03&showdescription=yes", "code_system": "WHO-ATC", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "524e246d-b393-4365-890a-a46c40a01edc", "code": "SUB08468MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "a5289cc5-2c9f-419f-a738-d047f45ab314", "code": "2651", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=2651", "code_system": "INN", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "fbb6dd38-7e4d-43ea-82cc-859efd936e5f", "code": "CORBILTA (AUTHORIZED: NERVOUS SYSTEM DISEASES)", "comments": "EMA EPAR|DISEASES|NERVOUS SYSTEM DISEASES", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002785/human_med_001700.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "439445d3-06ae-4946-93ef-f8e0252cbb36", "code": "CORBILTA (AUTHORIZED: NEURODEGENERATIVE DISEASES)", "comments": "EMA EPAR|DISEASES|NERVOUS SYSTEM DISEASES|NEURODEGENERATIVE DISEASES", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002785/human_med_001700.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "14533d20-5e62-4781-9c96-4e312cc46463", "code": "CORBILTA (AUTHORIZED: PARKINSON DISEASE)", "comments": "EMA EPAR|DISEASES|NERVOUS SYSTEM DISEASES|BRAIN DISEASES|BASAL GANGLIA DISEASES|PARKINSONIAN DISORDERS|PARKINSON DISEASE", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002785/human_med_001700.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "f8330332-b759-44a3-bfe0-1bb4ae077424", "code": "LEVODOPA/CARBIDOPA/ENTACAPONE ORION (AUTHORIZED: PARKINSON DISEASE)", "comments": "EMA EPAR|DISEASES|NERVOUS SYSTEM DISEASES|BRAIN DISEASES|BASAL GANGLIA DISEASES|PARKINSONIAN DISORDERS|PARKINSON DISEASE", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002441/human_med_001481.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "2f213911-0479-4519-bf4a-86171c73288c", "code": "STALEVO (AUTHORIZED: PARKINSON DISEASE)", "comments": "EMA EPAR|DISEASES|NERVOUS SYSTEM DISEASES|BRAIN DISEASES|BASAL GANGLIA DISEASES|PARKINSONIAN DISORDERS|PARKINSON DISEASE", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000511/human_med_001063.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "9c6412f5-6227-4792-a3e9-6d0ccf91ad36", "code": "3639", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3639", "code_system": "IUPHAR", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "4c2d64eb-956e-4a8f-b51d-1b98fe8d1123", "code": "C611", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C611", "code_system": "NCI_THESAURUS", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "1cc9252a-ad82-4383-b855-4d943e8728db", "code": "LEVODOPA", "comments": "Description: A white or almost white, crystalline powder; odourless. Solubility: Soluble in 300 parts of water; practically insoluble in ethanol (~750 g/l) TS and ether R. Category: Antiparkinsonism drug. Storage: Levodopa should be kept in a tightly closed container.Definition: Levodopa contains not less than 98.5% and not more than 101.0% of C9H11NO4, calculated with reference to the dried substance.", "type": "PRIMARY", "url": "http://apps.who.int/phint/pdf/b/Jb.6.1.241.pdf", "code_system": "WHO INTERNATIONAL PHARMACOPEIA", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "e73846fb-019c-4491-8247-37d74a5e383a", "code": "6375", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/6375/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "9d5b378d-93f7-4788-881f-c05d5bfd5c4c", "code": "m6786", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m6786?q=authorize", "code_system": "MERCK INDEX", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "d98117ba-eb0a-4aba-86f8-67bf506ba99c", "code": "DB01235", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB01235", "code_system": "DRUG BANK", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "5b418e73-cffd-44bd-bc48-a35fa176a5dd", "code": "CHEMBL1009", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1009", "code_system": "ChEMBL", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "adfdf0f3-c8cd-4667-842c-9f57ca4d7b28", "code": "200-445-2", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.000.405", "code_system": "ECHA (EC/EINECS)", "references": [ "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234" ] }, { "uuid": "707bf7f4-90e5-a1a9-8bc0-7164bea112a8", "code": "3348", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3348", "code_system": "HSDB", "references": [ "3e88da09-d520-3610-4363-3d655f41d103" ] }, { "uuid": "54da795e-c889-12e0-2652-54e8491be633", "code": "DTXSID9023209", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID9023209", "code_system": "EPA CompTox", "references": [ "3cf156b0-8a26-97f2-1d98-49a724419b96" ] }, { "uuid": "bae97726-9c90-8c5b-9404-178910c1a52a", "code": "129499", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of late stage Parkinson's disease", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=129499", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "e5bbf871-9db2-1062-7ddc-8db1aa0eac1f", "code": "C66884", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Dopamine Agonist", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C66884", "code_system": "NCI_THESAURUS", "references": [ "2bc7f03e-c8a5-597c-6342-d73df0d7f0d5" ] }, { "uuid": "a1a7845c-463f-4a3a-2964-f15adeedca9b", "code": "N0000193220", "comments": "Established Pharmacologic Class [EPC]|Aromatic Amino Acid [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000193220", "code_system": "NDF-RT", "references": [ "2bc7f03e-c8a5-597c-6342-d73df0d7f0d5" ] }, { "uuid": "81024a77-5b04-432b-7fd4-6f358601db6c", "code": "79577-3", "comments": "LOINC|ACTIVE|CHEM|Urine|Levodopa/Creatinine [Molar ratio] in Urine", "type": "PRIMARY", "url": "https://loinc.org/79577-3/", "code_system": "LOINC", "references": [ "393c8e4c-9f5a-a3c6-159e-8aa344cb117f" ] }, { "uuid": "18b1ab61-b9da-6244-9cba-2cbc7e829a73", "code": "EU/3/01/035", "comments": "EU ORPHAN DRUG|Positive|Treatment of advanced idiopathic Parkinson's disease with severe motor fluctuations", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu301035", "code_system": "EU-Orphan Drug", "references": [ "393c8e4c-9f5a-a3c6-159e-8aa344cb117f" ] }, { "uuid": "55f0840d-5223-4a40-89d8-35362e7de8ce", "code": "46627O600J", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "18750d31-ffb5-7cb5-28f5-de269ebbd24b", "code": "Levodopa", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM462/", "code_system": "LACTMED", "references": [ "393c8e4c-9f5a-a3c6-159e-8aa344cb117f" ] }, { "uuid": "03db47ef-006c-2421-e950-02e3d8cdfb73", "code": "6047", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/6047", "code_system": "PUBCHEM", "references": [ "0483a71b-cf45-8a9f-1b7e-b2add5c52aac" ] }, { "uuid": "38c59d41-1ed2-8135-2f69-1533ea7ad44f", "code": "1567", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/1567", "code_system": "DRUG CENTRAL", "references": [ "393c8e4c-9f5a-a3c6-159e-8aa344cb117f" ] }, { "uuid": "0b9415bf-c23a-dde9-4f51-fb79bf798986", "code": "1198 (Number of products:24)", "comments": "Dietary Supplement Label Database|Chemical|L-DOPA", "type": "PRIMARY", "url": "https://dsld.od.nih.gov/dsld/rptIngredient.jsp?grpid=1198&item=L-DOPA", "code_system": "DSLD", "references": [ "393c8e4c-9f5a-a3c6-159e-8aa344cb117f" ] }, { "uuid": "849af609-6745-d54b-551f-ebf7847ed3e6", "code": "15765", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:15765", "code_system": "CHEBI", "references": [ "393c8e4c-9f5a-a3c6-159e-8aa344cb117f" ] }, { "uuid": "6c3fc301-5f63-39f4-80cf-74bf3400339c", "code": "57504", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:57504", "code_system": "CHEBI", "references": [ "393c8e4c-9f5a-a3c6-159e-8aa344cb117f" ] }, { "uuid": "cbc23039-459d-1e8c-971d-2d2e145bc765", "code": "1361009", "type": "PRIMARY", "url": "https://store.usp.org/product/1361009", "code_system": "RS_ITEM_NUM", "references": [ "393c8e4c-9f5a-a3c6-159e-8aa344cb117f" ] }, { "uuid": "3bdd440f-5414-d0e2-4355-9a6adf38034b", "code": "118381", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=118381", "code_system": "NSC", "references": [ "a651cac5-ead1-d64d-2876-12ab7eb219f5" ] }, { "uuid": "833c516b-b5d9-a8e9-ce30-70995dddbba2", "code": "100000085446", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "65693907-e2d7-9b3b-e230-413b92de3c36" ] }, { "uuid": "69ba2714-9303-7353-7f93-79fd1d2e4f00", "code": "46627O600J", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=46627O600J", "code_system": "DAILYMED", "references": [ "75cec35b-e7c8-7a62-1679-1a45319fa4f4" ] } ], "substance_class": "chemical", "references": [ { "uuid": "480d6be7-40b8-4ecc-948b-aab1e459779e", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "5d990c5e-7893-4039-b62c-b0836b2dfa03", "citation": "FDA_SRS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "0f0d0016-2afe-44f7-a9d7-6814864f0c73", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "40195bbc-4d81-4e68-9e29-56273760ccc8", "citation": "INN Proposed List 21", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL21.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "762ca99b-15ab-4cb0-a57e-35011c197e1e", "citation": "USP DICTIONARY 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "05bd95af-f19e-494f-9ef6-229278e6b041", "citation": "EP 7.2", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "e87cb504-7577-45fe-a8fb-b70a90ddcd54", "citation": "USP 33", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "71398bd6-8851-465a-af8c-5b405491cc6a", "citation": "Drugs@FDA 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "ce986c00-ac82-437b-be23-4a45163745f3", "citation": "Drugs@FDA 2012", "doc_type": "DRUGS@FDA", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "3c534237-7214-41b0-8376-6c3dffcb08de", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "05ee6384-7bec-4638-b5e7-12f0e4b787ff", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "1cafb6f0-6391-4f59-a092-4bb4d0757922", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8134da8d-99c8-4618-b3bc-b206823e8e79", "citation": "EMA", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "bb01c265-2e7c-4959-b66a-6a65648ebd0c", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "003bb194-4855-4d82-a87d-a493ca46922e", "citation": "USP/NF", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "3ac7b9be-4167-4986-8a1f-931b861697ff", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7be0e3b9-791e-4787-a446-a673b3e36ba8", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "34f786e7-30f3-42f1-9926-1a3f89f87ce5", "citation": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002785/human_med_001700.", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002785/human_med_001700.", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "836806c9-10ea-43a6-898a-7249d382a734", "citation": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7", "url": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "48d4e75c-1227-4967-b8bd-fb8fd7dc211a", "citation": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7066d371-dc6a-0d6f-7bed-e5dd4ee912da", "url": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7066d371-dc6a-0d6f-7bed-e5dd4ee912da", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "e699fd9b-2106-4bb2-9487-c40d6df34a71", "citation": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002441/human_med_001481.", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002441/human_med_001481.", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "57f1497b-c7ca-4668-b425-239e106ac23e", "citation": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000511/human_med_001063.", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000511/human_med_001063.", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "78f26365-dcde-43f7-aaec-0d392296e9e4", "citation": "clintrials", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "3e291f52-bb2f-4a42-955f-3aeba968ec7f", "citation": "WHO-IP", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "70ceb1cf-b447-4c1b-8786-19e08dedcc53", "citation": "NCT00491998", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "4e6377a6-735d-4211-8c95-2e1485022cb0", "citation": "CHEMID", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5a421efe-46a9-44ef-9fdc-ea9c1e3e3234", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389659000, "tags": [ "NOMEN" ] }, { "uuid": "2621a58a-6adf-454a-bea4-560d94b2d064", "citation": "EP 7.8 LEVODOPA MONOGRAPH", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "126eb226-6c46-41e9-b87f-f9158e814080", "citation": "USP 36 LEVODOPA MONOGRAPH", "doc_type": "USP", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c093feb3-8a8b-4743-88ee-210149690abb", "citation": "http://www.accessdata.fda.gov/spl/data/9c16c0e0-3b97-486b-b7d5-579f5853e2c5/9c16c0e0-3b97-486b-b7d5-579f5853e2c5.xml", "url": "http://www.accessdata.fda.gov/spl/data/9c16c0e0-3b97-486b-b7d5-579f5853e2c5/9c16c0e0-3b97-486b-b7d5-579f5853e2c5.xml", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b90cdd9b-f775-4057-992d-5c314c0ab5c5", "citation": "http://www.cancer.gov/drugdictionary?cdrid=42622", "url": "http://www.cancer.gov/drugdictionary?cdrid=42622", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "048db5e5-8dae-4ada-8645-fdfcb45e3a46", "citation": "SRS import [46627O600J]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=46627O600J", "doc_type": "SRS", "public_domain": true, "document_date": 1493389659000, "tags": [ "NOMEN" ] }, { "uuid": "b962d603-764a-4b65-b1fb-8d14132616b8", "citation": "LEVODOPA [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "97981cab-2c78-4e45-b83e-d3a56c3780fc", "citation": "LEVODOPA [USAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "c493fb88-d80b-4f5e-b442-dc63ba84164a", "citation": "LEVODOPA [EP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "9d26c0c3-feef-4d9f-a4b9-78a98ca4ccef", "citation": "LEVODOPA [USP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "afd71cf8-8f8e-4bd7-8594-39b7bd0aa505", "citation": "LEVODOPA [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "d7c6a9b5-de5f-4419-a185-616ecc44a34f", "citation": "LEVODOPA [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "fc3bb7ff-3af9-419e-a230-e313c508615b", "citation": "LEVODOPA [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "86a03a43-7196-43b1-a01f-ea2eecb85c5c", "citation": "LEVODOPA [EMA EPAR]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "2f6aa1aa-f073-4adc-93b6-fb93575d17cf", "citation": "LEVODOPA [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "a6d5f306-9d6d-481b-a989-e4a0cac76981", "citation": "LEVODOPA [USP-RS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "ad196cfd-7cde-48ca-8c45-4a37a64cfaa3", "citation": "LEVODOPA [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "179a5b77-6499-4cfc-b157-1f26aba6e5a4", "citation": "LEVODOPA [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "8037393a-5717-47a1-a541-b6c93ed6d888", "citation": "LEVODOPA [WHO-IP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "3e88da09-d520-3610-4363-3d655f41d103", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+59-92-7", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "554b7665-b7bb-dde5-1ba3-45d10f732c41", "citation": "JAN", "doc_type": "SRS", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "NOMEN" ] }, { "uuid": "3cf156b0-8a26-97f2-1d98-49a724419b96", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=59-92-7", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "5798f98a-fcb0-6bc4-5f23-9a72a3d32af4", "citation": "Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease.\nSource: \tThe journal of pharmacology and experimental therapeutics [0022-3565] Lindén, I B yr:1988 vol:247 iss:1 pg:289 -293", "url": "http://jpet.aspetjournals.org/content/jpet/247/1/289.full.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "6bc469d3-585d-07b5-0611-18d642c46e43", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+59-92-7", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1218f651-2d21-36c0-3654-f67d044bd61e", "citation": "https://www.businesswire.com/news/home/20171207005333/en/Acorda-Resubmits-New-Drug-Application-INBRIJA%E2%84%A2-CVT-301", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "4056c610-e5cf-7064-c9c5-70e21125064d", "citation": "https://en.wikipedia.org/wiki/CVT-301", "doc_type": "WIKI", "public_domain": true }, { "uuid": "65693907-e2d7-9b3b-e230-413b92de3c36", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "6fdf25bb-1351-0663-78ae-562462461212", "citation": "https://clinicaltrials.gov/ct2/show/NCT02271503", "url": "https://clinicaltrials.gov/ct2/show/NCT02271503", "doc_type": "CLINICAL_TRIALS.GOV", "public_domain": true }, { "uuid": "2bc7f03e-c8a5-597c-6342-d73df0d7f0d5", "citation": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a906f8e1-6e1c-480a-8276-c01bc65dd3be", "doc_type": "SYSTEM", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1473392f-1a67-1471-d90d-08a79c067177", "citation": "DRUGBANK", "url": "https://www.drugbank.ca/drugs/DB01235", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8066292f-e761-4e8a-a2f6-7ae54e16342f", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a17da557-0457-6d65-0c42-13db1da56823", "citation": "Khor, Soo-Peang, and Ann Hsu. \"The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease.\" Current clinical pharmacology 2.3 (2007): 234-243.", "url": "https://www.ingentaconnect.com/content/ben/ccp/2007/00000002/00000003/art00006", "doc_type": "JA", "public_domain": true }, { "uuid": "00f4205b-8d89-4856-9030-1d55c203d326", "citation": "FDA_SRS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "313ba787-9f75-4f21-9865-b87f82131154", "citation": "Piccariello, Thomas, et al. \"Metal coordinated pharmaceuticals: a new technology for improved PK properties.\" Chimica Oggi-Chemistry Today 35 (2017): 4.", "url": "https://www.researchgate.net/profile/Robert_Oberlender/publication/320095943_Metal_coordinated_pharmaceuticals_A_new_technology_for_improved_PK_properties/links/59e4b16baca2724cbfe93575/Metal-coordinated-pharmaceuticals-A-new-technology-for-improved-PK-properties.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "393c8e4c-9f5a-a3c6-159e-8aa344cb117f", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "eb442e05-5e7b-c2ec-625f-0ce4bd7f55f7", "citation": "https://trademarks.justia.com/owners/avion-pharmaceuticals-llc-2780808/", "url": "https://trademarks.justia.com/owners/avion-pharmaceuticals-llc-2780808/", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "0483a71b-cf45-8a9f-1b7e-b2add5c52aac", "citation": "PUBCHEM", "doc_type": "PUBCHEM", "public_domain": true }, { "uuid": "55eda9e3-75a6-456e-a017-dfa3dad9543f", "citation": "https://en.wikipedia.org/wiki/L-DOPA", "doc_type": "WIKI", "public_domain": true }, { "uuid": "7829826c-4b45-41a7-bd5e-1837f207cdc9", "citation": "Lancet 1(7851):238;1974", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "f0af190b-469f-fd4c-2024-6b5c5df419f8", "citation": "USP 10/2020", "doc_type": "USPNF", "public_domain": true }, { "uuid": "4154a912-1c6e-2b54-5456-3d410750c45d", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true }, { "uuid": "49374b34-d5dd-060b-b4fb-0842611a3ae4", "citation": "DRUGS", "doc_type": "DRUGS@FDA", "public_domain": true }, { "uuid": "a651cac5-ead1-d64d-2876-12ab7eb219f5", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "96504394-24b3-4010-bff7-4ffd673f3278", "citation": "Khor, Soo-Peang, and Ann Hsu. \"The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease.\" Current clinical pharmacology 2.3 (2007): 234-243.", "url": "https://www.ingentaconnect.com/content/ben/ccp/2007/00000002/00000003/art00006", "doc_type": "JA", "public_domain": true }, { "uuid": "75cec35b-e7c8-7a62-1679-1a45319fa4f4", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "c0f420d0-c18a-2764-e209-7cd0f7d3bbd9", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "0fa4a2e5-6796-41b1-914f-8a442243e7cd", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217186s000lbl.pdf", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217186s000lbl.pdf", "doc_type": "DRUGS@FDA", "public_domain": true }, { "uuid": "248dad21-9421-4816-88a0-58eb404e8d8f", "citation": "Meiser, Johannes, Daniel Weindl, and Karsten Hiller. \"Complexity of dopamine metabolism.\" Cell Communication and Signaling 11 (2013): 1-18.", "url": "https://link.springer.com/content/pdf/10.1186/1478-811X-11-34.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "6cb5e7cb-5182-43b9-8c98-83fb77e3cd11", "citation": "FDA_SRS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "0750316d-ff63-46dc-a0a8-fe953359654c", "id": "0750316d-ff63-46dc-a0a8-fe953359654c", "molfile": "\n Marvin 01132100392D \n\n 14 14 0 0 1 0 999 V2000\n 5.1763 -3.8099 0.0000 C 0 0 1 0 0 0 0 0 0 2 0 0\n 5.1820 -4.6091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 4.4630 -3.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7412 -3.8357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7469 -4.6349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.0365 -5.0560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.3232 -4.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6185 -5.0990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.2974 -3.8586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.5841 -3.4461 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.9992 -3.4203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.8867 -3.3888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.8867 -2.5638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 6.5943 -3.8013 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 1 0 0 0\n 3 1 1 0 0 0 0\n 1 12 1 0 0 0 0\n 4 3 1 0 0 0 0\n 5 4 1 0 0 0 0\n 11 4 2 0 0 0 0\n 6 5 2 0 0 0 0\n 7 6 1 0 0 0 0\n 8 7 1 0 0 0 0\n 9 7 2 0 0 0 0\n 10 9 1 0 0 0 0\n 9 11 1 0 0 0 0\n 13 12 1 0 0 0 0\n 14 12 2 0 0 0 0\nM END", "smiles": "c1cc(c(cc1C[C@@H](C(=O)O)N)O)O", "formula": "C9H11NO4", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "6215788a-686b-42af-8e5c-2273c6e69465" }, "defined_stereo": 1, "ez_centers": 0, "molecular_weight": "197.1883", "optical_activity": "UNSPECIFIED", "stereo_centers": 1 } ], "definition_level": "COMPLETE", "uuid": "81ced566-c75d-4557-8ae1-427313f497a4", "version": "77", "structure": { "id": "88f273d5-04d5-44be-b82f-61cd7fea8f18", "molfile": "\n Marvin 01132107062D \n\n 14 14 0 0 1 0 999 V2000\n 5.8867 -3.3888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.2974 -3.8586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.1763 -3.8099 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 2.3232 -4.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.9992 -3.4203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7412 -3.8357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.4630 -3.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.8867 -2.5638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.0365 -5.0560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.1820 -4.6091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 6.5943 -3.8013 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7469 -4.6349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.5841 -3.4461 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6185 -5.0990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2 5 1 0 0 0 0\n 3 1 1 0 0 0 0\n 4 9 1 0 0 0 0\n 5 6 2 0 0 0 0\n 6 7 1 0 0 0 0\n 7 3 1 0 0 0 0\n 8 1 2 0 0 0 0\n 9 12 2 0 0 0 0\n 3 10 1 1 0 0 0\n 11 1 1 0 0 0 0\n 12 6 1 0 0 0 0\n 13 2 1 0 0 0 0\n 14 4 1 0 0 0 0\n 2 4 2 0 0 0 0\nM END", "smiles": "c1cc(c(cc1C[C@@H](C(=O)O)N)O)O", "formula": "C9H11NO4", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "defined_stereo": 1, "ez_centers": 0, "molecular_weight": "197.1883", "optical_activity": "UNSPECIFIED", "references": [ "480d6be7-40b8-4ecc-948b-aab1e459779e", "048db5e5-8dae-4ada-8645-fdfcb45e3a46", "40195bbc-4d81-4e68-9e29-56273760ccc8" ], "stereo_centers": 1 }, "unii": "46627O600J", "relationships": [ { "uuid": "18415740-5174-4f76-bc1c-36f1a3993d75", "amount": { "uuid": "e235bb3f-f662-4b34-bfa4-8af9b6278765" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "6527e5e2-37a7-4d93-ad4d-cd664f1916ca", "refuuid": "81ced566-c75d-4557-8ae1-427313f497a4", "name": "LEVODOPA", "unii": "46627O600J", "linking_id": "46627O600J", "ref_pname": "LEVODOPA", "substance_class": "reference" } }, { "uuid": "d1065526-b469-405f-a1a1-34247aeee7cb", "amount": { "uuid": "2b16a305-c4ad-4513-bd54-657efafc99a2", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 101, "low_limit": 99 }, "qualification": "EP", "type": "BASIS OF STRENGTH->SUBSTANCE", "interaction_type": "ASSAY (TITRATION)", "references": [ "2621a58a-6adf-454a-bea4-560d94b2d064" ], "related_substance": { "uuid": "777bd2ee-771d-40a6-bc37-cef5ce615b05", "refuuid": "81ced566-c75d-4557-8ae1-427313f497a4", "name": "LEVODOPA", "unii": "46627O600J", "linking_id": "46627O600J", "ref_pname": "LEVODOPA", "substance_class": "reference" } }, { "uuid": "9ff97822-968a-40e5-8bf2-3407e7794b1c", "amount": { "uuid": "73fd8bc3-5f35-4493-a2e1-98017609b6c1", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 102, "low_limit": 98 }, "qualification": "USP", "type": "BASIS OF STRENGTH->SUBSTANCE", "interaction_type": "ASSAY (HPLC)", "references": [ "126eb226-6c46-41e9-b87f-f9158e814080" ], "related_substance": { "uuid": "3c139ce6-1d3b-40f0-a595-ab92577abcbb", "refuuid": "81ced566-c75d-4557-8ae1-427313f497a4", "name": "LEVODOPA", "unii": "46627O600J", "linking_id": "46627O600J", "ref_pname": "LEVODOPA", "substance_class": "reference" } }, { "uuid": "5250116b-eb0a-4927-8c82-2208e3b76acd", "amount": { "uuid": "72dbb913-214a-4d0d-82dc-8366a55b938e", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT PEAK AREA", "high_limit": 0.5 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "2621a58a-6adf-454a-bea4-560d94b2d064" ], "related_substance": { "uuid": "355c8f38-1d9a-4522-bb57-e13c0d4a1a18", "refuuid": "1ef17d0a-c634-43a5-8b5e-fe6c195f3f5b", "name": "DOPA, D-", "unii": "8T862R29FY", "linking_id": "8T862R29FY", "ref_pname": "DOPA, D-", "substance_class": "reference" } }, { "uuid": "cc0cc9c6-b7c3-4239-9ca2-ba873c7f6b9a", "amount": { "uuid": "0006ad5a-d842-4c82-88b0-2ffb9d8b5f5c", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 0.1 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "126eb226-6c46-41e9-b87f-f9158e814080" ], "related_substance": { "uuid": "8cedb492-f911-4c29-a993-97787ccbe10f", "refuuid": "1fc7e81e-e31a-4ef1-bcd5-f2924d81800d", "name": "3,4-DIMETHOXYPHENYLALANINE, L-", "unii": "GC6UEI64EC", "linking_id": "GC6UEI64EC", "ref_pname": "3,4-DIMETHOXYPHENYLALANINE, L-", "substance_class": "reference" } }, { "uuid": "6a2c5151-6a05-413a-aa71-f9bb59f9f298", "amount": { "uuid": "579c0b29-ab20-48bd-97bf-a072f5015ae1", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "2621a58a-6adf-454a-bea4-560d94b2d064" ], "related_substance": { "uuid": "3b66e420-632b-471b-9688-85cdc32eb43f", "refuuid": "e6124499-22e7-476a-bb51-06a72cfa618e", "name": "6-HYDROXYDOPA, L-", "unii": "580PK2O48O", "linking_id": "580PK2O48O", "ref_pname": "6-HYDROXYDOPA, L-", "substance_class": "reference" } }, { "uuid": "53974463-3aa9-4adf-83cc-98e2744a401f", "amount": { "uuid": "46ca5f4e-f9a7-4d67-8d21-e47af8a691ea", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 0.1 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "126eb226-6c46-41e9-b87f-f9158e814080" ], "related_substance": { "uuid": "c487a3d5-cdf7-4eb1-8766-5dbae4b21e44", "refuuid": "e6124499-22e7-476a-bb51-06a72cfa618e", "name": "6-HYDROXYDOPA, L-", "unii": "580PK2O48O", "linking_id": "580PK2O48O", "ref_pname": "6-HYDROXYDOPA, L-", "substance_class": "reference" } }, { "uuid": "935bf065-8ac8-4c7c-91e6-4ed06318160c", "amount": { "uuid": "dc15c350-ba38-4339-b1e3-780dd4770a1d", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT PEAK AREA (CORRECTION FACTOR)", "high_limit": 0.5 }, "comments": "For the calculation of contents, multiply the peak areas by 2.2", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "2621a58a-6adf-454a-bea4-560d94b2d064" ], "related_substance": { "uuid": "c53f9a06-a952-4fd8-a255-517711e7fd88", "refuuid": "c046990c-117a-4cde-bf88-3d61abd25ab2", "name": "TYROSINE", "unii": "42HK56048U", "linking_id": "42HK56048U", "ref_pname": "TYROSINE", "substance_class": "reference" } }, { "uuid": "74a38b01-1bb5-41c9-a9bd-c9c093c669f5", "amount": { "uuid": "88f91808-937d-42d9-a9ee-40dfba1aee33", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 0.1 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "126eb226-6c46-41e9-b87f-f9158e814080" ], "related_substance": { "uuid": "f2fd169c-e664-4e90-a214-2b85e147b722", "refuuid": "c046990c-117a-4cde-bf88-3d61abd25ab2", "name": "TYROSINE", "unii": "42HK56048U", "linking_id": "42HK56048U", "ref_pname": "TYROSINE", "substance_class": "reference" } }, { "uuid": "289960c9-4ce8-490e-a045-862f60352e56", "amount": { "uuid": "ea1e8a84-9858-4e40-ae1e-95fc89a15cda", "type": "RELATIONSHIP_AMOUNT", "units": "PERCENT PEAK AREA", "high_limit": 0.2 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "2621a58a-6adf-454a-bea4-560d94b2d064" ], "related_substance": { "uuid": "ed3bd253-d51a-4a61-939d-f13f08932649", "refuuid": "a4734370-4844-493f-aa49-61d2cf816250", "name": "3-O-METHYLDOPA, DL-", "unii": "SO86T1OB2P", "linking_id": "SO86T1OB2P", "ref_pname": "3-O-METHYLDOPA, DL-", "substance_class": "reference" } }, { "uuid": "9f48ab01-7000-4db1-95cf-95d4e7019cdf", "amount": { "uuid": "b3d2459f-479e-4aa6-94d5-708a495522bc", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 0.5 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "126eb226-6c46-41e9-b87f-f9158e814080" ], "related_substance": { "uuid": "c054ee1e-3eee-41d6-a7fe-9e719a0a8564", "refuuid": "a4734370-4844-493f-aa49-61d2cf816250", "name": "3-O-METHYLDOPA, DL-", "unii": "SO86T1OB2P", "linking_id": "SO86T1OB2P", "ref_pname": "3-O-METHYLDOPA, DL-", "substance_class": "reference" } }, { "uuid": "7a41cea3-2574-4d4c-b5c6-b8e598f61ea3", "amount": { "uuid": "048eaca8-e6c1-4771-8cb4-547cbcd1b7c5" }, "type": "PRODRUG->METABOLITE ACTIVE", "related_substance": { "uuid": "7f7ab3cf-2959-47f6-ac16-0bde0fc9728a", "refuuid": "aecd5dc7-9999-450a-9e26-bf0831479e63", "name": "MELEVODOPA", "unii": "M30686U4X4", "linking_id": "M30686U4X4", "ref_pname": "MELEVODOPA", "substance_class": "reference" } }, { "uuid": "0415deb2-0807-4313-ad69-3408551aa6cb", "amount": { "uuid": "0b168992-5eec-419a-9fb3-6b002f7d1f52" }, "type": "PRODRUG->METABOLITE ACTIVE", "related_substance": { "uuid": "ebf91736-10f8-48d6-8e76-a726cf6bf9c4", "refuuid": "8173b5b8-2580-400c-b97f-1c293e1fe05b", "name": "ETILEVODOPA", "unii": "895X917GYE", "linking_id": "895X917GYE", "ref_pname": "ETILEVODOPA", "substance_class": "reference" } }, { "uuid": "c2ec04a9-0985-4ba7-9288-9120eb0143dc", "amount": { "uuid": "51abff5f-5b00-4113-8d01-7fe69088e125" }, "comments": "When decarboxylation of levodopa is prevented by carbidopa, COMT becomes the major metabolizing enzyme for levodopa, catalyzing its metabolism to 3-methoxy-4-hydroxy-L-phenylalanine (3-OMD).", "type": "METABOLITE->PARENT", "mediator_substance": { "uuid": "30a7fe5f-e18f-4bbf-b768-217223158d00", "refuuid": "46a76c73-550a-4aab-ad26-460b6a357de9", "name": "CATECHOL O-METHYLTRANSFERASE", "unii": "22Q832K2UN", "linking_id": "22Q832K2UN", "ref_pname": "CATECHOL O-METHYLTRANSFERASE", "substance_class": "reference" }, "references": [ "c093feb3-8a8b-4743-88ee-210149690abb" ], "related_substance": { "uuid": "91517f0f-8378-4c7e-8edf-e054f9ff7269", "refuuid": "5ed9b9ff-0bcc-4572-b817-3d8eb934c0fa", "name": "3-O-METHYLDOPA", "unii": "V3O7J20DWN", "linking_id": "V3O7J20DWN", "ref_pname": "3-O-METHYLDOPA", "substance_class": "reference" } }, { "uuid": "9134facf-537b-41bc-80cc-6878f95ae03a", "amount": { "uuid": "41459f01-4f7f-45cb-872c-40cf04c54b5f" }, "type": "METABOLITE ACTIVE->PRODRUG", "interaction_type": "MAJOR", "mediator_substance": { "uuid": "37369e98-8ee3-4611-a498-aef834546861", "refuuid": "c8b84f6a-3338-4734-bff3-cd16eeae7639", "name": "AROMATIC-L-AMINO-ACID DECARBOXYLASE", "unii": "BY6OQ7Q6TP", "linking_id": "BY6OQ7Q6TP", "ref_pname": "AROMATIC-L-AMINO-ACID DECARBOXYLASE", "substance_class": "reference" }, "references": [ "55eda9e3-75a6-456e-a017-dfa3dad9543f" ], "related_substance": { "uuid": "6d33171f-8f13-47b3-b3b3-b53bfe8c8962", "refuuid": "11cfc6b9-4651-4a5c-98b9-284d8fbe2b50", "name": "DOPAMINE", "unii": "VTD58H1Z2X", "linking_id": "VTD58H1Z2X", "ref_pname": "DOPAMINE", "substance_class": "reference" } }, { "uuid": "39c0b7df-6cc3-49df-b272-083d0e6118f4", "amount": { "uuid": "4f857551-f9c2-41f6-8fb0-c83e92c78cfe" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "5798f98a-fcb0-6bc4-5f23-9a72a3d32af4" ], "related_substance": { "uuid": "8dd6ed0d-258b-4ea5-8262-2ea2149a1608", "refuuid": "46a76c73-550a-4aab-ad26-460b6a357de9", "name": "CATECHOL O-METHYLTRANSFERASE", "unii": "22Q832K2UN", "linking_id": "22Q832K2UN", "ref_pname": "CATECHOL O-METHYLTRANSFERASE", "substance_class": "reference" } }, { "uuid": "2bc750af-ca2e-4076-a10b-64a54d911395", "amount": { "uuid": "4f4168a5-b6d4-498c-bb4b-439a30d8165e" }, "type": "PRODRUG->METABOLITE ACTIVE", "references": [ "6cb5e7cb-5182-43b9-8c98-83fb77e3cd11" ], "related_substance": { "uuid": "311edd5b-18e5-47c1-9d5a-34826ce432ff", "refuuid": "4ab6a59c-3470-4d59-bde3-182b9ad87aef", "name": "FOSLEVODOPA", "unii": "37NQZ0J76I", "linking_id": "37NQZ0J76I", "ref_pname": "FOSLEVODOPA" } }, { "uuid": "70524957-5017-4502-ac12-79b02161a07a", "type": "PRODRUG->METABOLITE ACTIVE", "references": [ "313ba787-9f75-4f21-9865-b87f82131154" ], "related_substance": { "uuid": "2efff231-05d9-4a00-9314-166d78c092a8", "refuuid": "fa5016ea-4af4-4d77-8276-a75b7993ddc7", "name": "BISMUTH SUBDOPATE", "unii": "G69RN28K8B", "linking_id": "G69RN28K8B", "ref_pname": "BISMUTH SUBDOPATE" } }, { "uuid": "591af02f-d429-45f0-be23-861aa21918a5", "amount": { "uuid": "68c133b0-90fc-46ad-a41c-cf1dca61e77e", "type": "WEIGHT PERCENT", "units": "%", "high_limit": 0.1, "non_numeric_value": "peak value" }, "type": "PARENT->IMPURITY", "related_substance": { "uuid": "a74caf43-069a-4a46-a2bc-bc48449c9681", "refuuid": "38b2c012-0353-4034-a6cc-03cf8e2152b0", "name": "6-HYDROXYDOPA, DL-", "unii": "9HBL9XYQ8O", "linking_id": "9HBL9XYQ8O", "ref_pname": "6-HYDROXYDOPA, DL-" } }, { "uuid": "8bcb45d1-17c4-4ebc-8506-c7eeab07fd59", "amount": { "uuid": "f1bf9a13-b7ac-4007-b93b-e4aafe9d4eba" }, "type": "METABOLITE ACTIVE->PRODRUG", "references": [ "96504394-24b3-4010-bff7-4ffd673f3278" ], "related_substance": { "uuid": "e8958348-56ed-4a4d-85c1-748d443333b7", "refuuid": "11cfc6b9-4651-4a5c-98b9-284d8fbe2b50", "name": "DOPAMINE", "unii": "VTD58H1Z2X", "linking_id": "VTD58H1Z2X", "ref_pname": "DOPAMINE", "substance_class": "reference" } }, { "uuid": "6acc2dc9-78fe-4e4c-912c-cc8e330a1884", "type": "PARENT->CONSTITUENT ALWAYS PRESENT", "related_substance": { "uuid": "9932f195-cf9e-429d-9a0d-6a707801de8e", "refuuid": "e97b20f7-aa68-4c33-b5e5-131dba42f09b", "name": "MUCUNA PRURIENS SEED", "unii": "55G8SQ543S", "linking_id": "55G8SQ543S", "ref_pname": "MUCUNA PRURIENS SEED" } }, { "uuid": "fc186e91-245a-46e6-829c-a99da85ed692", "type": "TARGET->AGONIST", "references": [ "1473392f-1a67-1471-d90d-08a79c067177" ], "related_substance": { "uuid": "1eb1e6ef-ecfa-4e0b-a06b-35302021d39a", "refuuid": "84edf12e-87a3-43e0-8526-ad45513dcd09", "name": "D(1A) DOPAMINE RECEPTOR", "unii": "54202V7DRJ", "linking_id": "54202V7DRJ", "ref_pname": "D(1A) DOPAMINE RECEPTOR", "substance_class": "reference" } }, { "uuid": "c652eff2-50c1-4ebd-a0d8-e19b45d143b1", "amount": { "uuid": "92dbd689-f5e0-4bd4-96ca-2a40de078c14" }, "type": "METABOLITE->PARENT", "references": [ "7829826c-4b45-41a7-bd5e-1837f207cdc9" ], "related_substance": { "uuid": "594e965d-7de5-4861-bb6f-6b6a9dc2fc5a", "refuuid": "39081d18-38a9-47c9-b7fb-c92b7cd51f54", "name": "3-HYDROXYBENZENEACETIC ACID", "unii": "K59Z6Z8REF", "linking_id": "K59Z6Z8REF", "ref_pname": "3-HYDROXYBENZENEACETIC ACID" } }, { "uuid": "0c51a423-3b12-44df-9b00-4ce8c333f24b", "amount": { "uuid": "b58cbf15-29fb-4d44-8a69-b76d96b16a6f", "non_numeric_value": "Negligible" }, "type": "BINDER->LIGAND", "interaction_type": "BINDING", "related_substance": { "uuid": "60fc47b5-daac-412c-b757-51e79e5b903e", "refuuid": "e95d330b-4c2d-44bb-a61b-860afeb4aa30", "name": "PLASMA PROTEIN FRACTION (HUMAN)", "unii": "6D53G0FD0Z", "linking_id": "6D53G0FD0Z", "ref_pname": "PLASMA PROTEIN FRACTION (HUMAN)", "substance_class": "reference" } }, { "uuid": "25d0d5f6-78dc-4968-a9c6-96dbbb77d989", "amount": { "uuid": "f44f0dd5-6beb-4f92-b3c9-7335a182e26b" }, "type": "PARENT->METABOLITE", "mediator_substance": { "uuid": "0562ed68-7a8c-4cfc-8737-5835bdba4f5e", "refuuid": "c8e7ead5-cfcb-4d4a-a327-938877c82bda", "name": "TYROSINASE", "unii": "G2UX40NTG9", "linking_id": "G2UX40NTG9", "ref_pname": "TYROSINASE", "substance_class": "reference" }, "references": [ "248dad21-9421-4816-88a0-58eb404e8d8f" ], "related_substance": { "uuid": "d65d6399-66d5-4cc2-ad98-ca114f3f5408", "refuuid": "c046990c-117a-4cde-bf88-3d61abd25ab2", "name": "TYROSINE", "unii": "42HK56048U", "linking_id": "42HK56048U", "ref_pname": "TYROSINE", "substance_class": "reference" } } ], "names": [ { "uuid": "c92fd0e2-9376-4ce3-b297-52444699e0a7", "name": "(-)-3-(3,4-DIHYDROXYPHENYL)-L-ALANINE", "stdName": "(-)-3-(3,4-DIHYDROXYPHENYL)-L-ALANINE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "0f0d0016-2afe-44f7-a9d7-6814864f0c73" ], "display_name": false }, { "uuid": "48218d27-acff-47f2-9549-d9dd0b7d17ba", "name": "BENDOPA", "stdName": "BENDOPA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "0f0d0016-2afe-44f7-a9d7-6814864f0c73" ], "display_name": false }, { "uuid": "14a94bf2-ace3-46ea-b54c-6d8823ff568c", "name": "CARBILEV COMPONENT LEVODOPA", "stdName": "CARBILEV COMPONENT LEVODOPA", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "ce986c00-ac82-437b-be23-4a45163745f3", "71398bd6-8851-465a-af8c-5b405491cc6a" ], "display_name": false }, { "uuid": "3191b1a2-0a20-47f1-8940-8a3ba5153e5d", "name": "CORBILTA COMPONENT LEVODOPA", "stdName": "CORBILTA COMPONENT LEVODOPA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "34f786e7-30f3-42f1-9926-1a3f89f87ce5" ], "display_name": false }, { "uuid": "90fa22f9-a430-4dcc-b8f6-02689213d04a", "name": "CREXONT COMPONENT LEVODOPA", "stdName": "CREXONT COMPONENT LEVODOPA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "0fa4a2e5-6796-41b1-914f-8a442243e7cd" ], "display_name": false }, { "uuid": "e67b77f3-e4e1-995b-cbf6-f5815bc3a138", "name": "CVT-301", "stdName": "CVT-301", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4056c610-e5cf-7064-c9c5-70e21125064d" ], "display_name": false }, { "uuid": "d191c890-c2e9-fe1f-9bd2-460232f1f67c", "name": "DHIVY COMPONENT LEVODOPA", "stdName": "DHIVY COMPONENT LEVODOPA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "49374b34-d5dd-060b-b4fb-0842611a3ae4" ], "display_name": false }, { "uuid": "c58b598e-cf04-4694-9af1-c8d3a62eac37", "name": "DIHYDROXYPHENYLALANINE", "stdName": "DIHYDROXYPHENYLALANINE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "78f26365-dcde-43f7-aaec-0d392296e9e4" ], "display_name": false }, { "uuid": "e64eb723-06b1-4bc5-8e93-c607a2505938", "name": "DOPA, L-", "stdName": "DOPA, L-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "5d990c5e-7893-4039-b62c-b0836b2dfa03" ], "display_name": false }, { "uuid": "8a98b7c3-4bc4-4d86-b602-a1d1aafac8bb", "name": "DOPAR", "stdName": "DOPAR", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "0f0d0016-2afe-44f7-a9d7-6814864f0c73" ], "display_name": false }, { "uuid": "e573e003-3f25-4942-3c51-298527f49e37", "name": "DOPASNAP COMPONENT LEVODOPA", "stdName": "DOPASNAP COMPONENT LEVODOPA", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "eb442e05-5e7b-c2ec-625f-0ce4bd7f55f7" ], "display_name": false }, { "uuid": "8f0967d0-7f4f-4427-bb93-aa4c0c0ff4c8", "name": "DUOPA COMPONENT LEVODOPA", "stdName": "DUOPA COMPONENT LEVODOPA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "48d4e75c-1227-4967-b8bd-fb8fd7dc211a" ], "display_name": false }, { "uuid": "f8cc62d1-5824-e11b-4613-988f2d4e7b90", "name": "INBRIJA", "stdName": "INBRIJA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "1218f651-2d21-36c0-3654-f67d044bd61e", "2bc7f03e-c8a5-597c-6342-d73df0d7f0d5" ], "display_name": false }, { "uuid": "b37d613c-84de-a0ee-7bea-f5fe0febc175", "name": "IPX-203 COMPONENT LEVODOPA", "stdName": "IPX-203 COMPONENT LEVODOPA", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "6fdf25bb-1351-0663-78ae-562462461212" ], "display_name": false }, { "uuid": "89dfb3ff-8cb6-1b80-6b50-7ec24d99cb4a", "name": "IPX203 COMPONENT LEVODOPA", "stdName": "IPX203 COMPONENT LEVODOPA", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "6fdf25bb-1351-0663-78ae-562462461212" ], "display_name": false }, { "uuid": "3e394c1c-ef9f-4b26-b411-a6e302dff6a1", "name": "L-DOPA", "stdName": "L-DOPA", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "5d990c5e-7893-4039-b62c-b0836b2dfa03" ], "display_name": false }, { "uuid": "e322bc0f-fff2-4d8f-a8ee-fe297dad7426", "name": "L-TYROSINE, 3-HYDROXY-", "stdName": "L-TYROSINE, 3-HYDROXY-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "0f0d0016-2afe-44f7-a9d7-6814864f0c73" ], "display_name": false }, { "uuid": "8350077e-7117-4db1-8f3a-2f46a0c5f6a1", "name": "LARODOPA", "stdName": "LARODOPA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "0f0d0016-2afe-44f7-a9d7-6814864f0c73" ], "display_name": false }, { "uuid": "f79f5e46-73ba-4fcd-b62d-e4ebf45b0ebb", "name": "LEVODOPA", "stdName": "LEVODOPA", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "05bd95af-f19e-494f-9ef6-229278e6b041", "762ca99b-15ab-4cb0-a57e-35011c197e1e", "ad196cfd-7cde-48ca-8c45-4a37a64cfaa3", "afd71cf8-8f8e-4bd7-8594-39b7bd0aa505", "3c534237-7214-41b0-8376-6c3dffcb08de", "480d6be7-40b8-4ecc-948b-aab1e459779e", "1cafb6f0-6391-4f59-a092-4bb4d0757922", "9d26c0c3-feef-4d9f-a4b9-78a98ca4ccef", "c493fb88-d80b-4f5e-b442-dc63ba84164a", "e87cb504-7577-45fe-a8fb-b70a90ddcd54", "003bb194-4855-4d82-a87d-a493ca46922e", "fc3bb7ff-3af9-419e-a230-e313c508615b", "97981cab-2c78-4e45-b83e-d3a56c3780fc", "7be0e3b9-791e-4787-a446-a673b3e36ba8", "3e291f52-bb2f-4a42-955f-3aeba968ec7f", "b962d603-764a-4b65-b1fb-8d14132616b8", "bb01c265-2e7c-4959-b66a-6a65648ebd0c", "3ac7b9be-4167-4986-8a1f-931b861697ff", "8037393a-5717-47a1-a541-b6c93ed6d888", "40195bbc-4d81-4e68-9e29-56273760ccc8", "05ee6384-7bec-4638-b5e7-12f0e4b787ff", "86a03a43-7196-43b1-a01f-ea2eecb85c5c", "2f6aa1aa-f073-4adc-93b6-fb93575d17cf", "d7c6a9b5-de5f-4419-a185-616ecc44a34f", "179a5b77-6499-4cfc-b157-1f26aba6e5a4", "a6d5f306-9d6d-481b-a989-e4a0cac76981", "8134da8d-99c8-4618-b3bc-b206823e8e79" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "0d82ced3-9d28-4ab8-b982-fd053dd12c92", "name_org": "INN" }, { "uuid": "ab78b6d7-db7e-41b8-8c2f-692a9778678a", "name_org": "USAN" } ] }, { "uuid": "36515b16-d867-4c5a-9bf7-dbeb8f1d6771", "name": "LEVODOPA [EMA EPAR]", "stdName": "LEVODOPA [EMA EPAR]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "8134da8d-99c8-4618-b3bc-b206823e8e79" ], "display_name": false }, { "uuid": "74e5b8b5-1cd7-79d4-f954-54677df56ada", "name": "LEVODOPA [EP IMPURITY]", "stdName": "LEVODOPA [EP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "05bd95af-f19e-494f-9ef6-229278e6b041" ], "display_name": false }, { "uuid": "a352d71f-bbb6-2886-3e29-fe856e948cf8", "name": "LEVODOPA [EP MONOGRAPH]", "stdName": "LEVODOPA [EP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4154a912-1c6e-2b54-5456-3d410750c45d" ], "display_name": false }, { "uuid": "a16619fe-14a1-4ab9-8b43-3dbd54517154", "name": "LEVODOPA [HSDB]", "stdName": "LEVODOPA [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "bb01c265-2e7c-4959-b66a-6a65648ebd0c" ], "display_name": false }, { "uuid": "04357644-ee40-47ce-9668-202f965af81c", "name": "LEVODOPA [JAN]", "stdName": "LEVODOPA [JAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "554b7665-b7bb-dde5-1ba3-45d10f732c41" ], "display_name": false }, { "uuid": "f3b5a138-42e7-47f9-9817-ed74c7af65a9", "name": "LEVODOPA [MART.]", "stdName": "LEVODOPA [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "05ee6384-7bec-4638-b5e7-12f0e4b787ff" ], "display_name": false }, { "uuid": "b7061ca3-871c-4c3b-a412-aa46ac6ba845", "name": "LEVODOPA [MI]", "stdName": "LEVODOPA [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "1cafb6f0-6391-4f59-a092-4bb4d0757922" ], "display_name": false }, { "uuid": "3093932b-15a1-4c37-8a4c-3eb46a5c80f5", "name": "LEVODOPA [ORANGE BOOK]", "stdName": "LEVODOPA [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "3c534237-7214-41b0-8376-6c3dffcb08de" ], "display_name": false }, { "uuid": "599af7cf-ed81-418c-9ba7-ab3cd4f6f296", "name": "LEVODOPA [USAN]", "stdName": "LEVODOPA [USAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "762ca99b-15ab-4cb0-a57e-35011c197e1e" ], "display_name": false }, { "uuid": "62c9057e-8b0b-3bb9-9826-72fb828ab76c", "name": "LEVODOPA [USP MONOGRAPH]", "stdName": "LEVODOPA [USP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f0af190b-469f-fd4c-2024-6b5c5df419f8" ], "display_name": false }, { "uuid": "40f142e9-3da4-4025-abaa-37927b1f99aa", "name": "LEVODOPA [USP-RS]", "stdName": "LEVODOPA [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "003bb194-4855-4d82-a87d-a493ca46922e" ], "display_name": false }, { "uuid": "ff159ef2-6501-4df8-b475-d66a39ca9490", "name": "LEVODOPA [VANDF]", "stdName": "LEVODOPA [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "7be0e3b9-791e-4787-a446-a673b3e36ba8" ], "display_name": false }, { "uuid": "2bea7aec-d52c-486c-8257-4057e92afca6", "name": "LEVODOPA [WHO-IP]", "stdName": "LEVODOPA [WHO-IP]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "3e291f52-bb2f-4a42-955f-3aeba968ec7f" ], "display_name": false }, { "uuid": "696aaa27-f49b-4489-a3cf-e8c6419e01eb", "name": "LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT LEVODOPA", "stdName": "LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT LEVODOPA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "e699fd9b-2106-4bb2-9487-c40d6df34a71" ], "display_name": false }, { "uuid": "dd427d02-bf48-49b3-a5e1-8b0278eede27", "name": "LEVODOPUM [WHO-IP LATIN]", "stdName": "LEVODOPUM [WHO-IP LATIN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "3e291f52-bb2f-4a42-955f-3aeba968ec7f" ], "display_name": false }, { "uuid": "cbcea63e-4148-e6a0-0dcf-c3aa8b8ffda8", "name": "Levodopa [WHO-DD]", "stdName": "LEVODOPA [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c0f420d0-c18a-2764-e209-7cd0f7d3bbd9" ], "display_name": false }, { "uuid": "c8d8c282-b380-4ae4-91a4-8a2c5db8468a", "name": "NSC-118381", "stdName": "NSC-118381", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "4e6377a6-735d-4211-8c95-2e1485022cb0" ], "display_name": false }, { "uuid": "90736395-4224-4004-beae-ce6ccc324776", "name": "PARCOPA COMPONENT LEVODOPA", "stdName": "PARCOPA COMPONENT LEVODOPA", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "ce986c00-ac82-437b-be23-4a45163745f3", "71398bd6-8851-465a-af8c-5b405491cc6a" ], "display_name": false }, { "uuid": "05b0833d-2a67-41a9-9c1d-bb081747c495", "name": "RYTARY COMPONENT LEVODOPA", "stdName": "RYTARY COMPONENT LEVODOPA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "836806c9-10ea-43a6-898a-7249d382a734" ], "display_name": false }, { "uuid": "7976a593-cd6c-48ae-a8d1-b4856837034a", "name": "STALEVO COMPONENT LEVODOPA", "stdName": "STALEVO COMPONENT LEVODOPA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "57f1497b-c7ca-4668-b425-239e106ac23e" ], "display_name": false }, { "uuid": "2252cefe-d237-41d7-907a-9b7366a96442", "name": "V-1512", "stdName": "V-1512", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "70ceb1cf-b447-4c1b-8786-19e08dedcc53" ], "display_name": false }, { "uuid": "18cd101b-866f-4bc8-8570-d8a615ecc93b", "name": "levodopa [INN]", "stdName": "LEVODOPA [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "40195bbc-4d81-4e68-9e29-56273760ccc8" ], "display_name": false } ], "modifications": { "uuid": "3ec3b866-008f-4e63-8a69-9a935c5bfa03" } } ] }